NASDAQ · NMTC
NeuroOne Medical Technologies Corporation
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for NMTC: Dec 15, 2026
NeuroOne Medical Technologies Corporation Common Stock is estimated to report earnings on 12/15/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. The reported EPS for the same quarter last year was $-0.24.
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · The Motley Fool · Fintel · BNK Invest- RTTNews · Oct 5, 9:57 AM EDTNeuroOne Gains After Q4 Product Revenue Rises 38%(RTTNews) – NeuroOne Medical Technologies Corp. (NMTC), a medical technology company focused on surgical care solutions for patients with neurological disorders, announced preliminary fourth-quarter results showing 38.4% revenue growth and provided an update on recent orders.
- RTTNews · Aug 21, 12:09 PM EDTNeuroOne's Q3 Revenue Rises 16%; Gross Margin Expands To 59.9%; Stock Down(RTTNews) – NeuroOne Medical Technologies Corporation (NMTC), a medical technology company focused on neurological disorders, recently reported fiscal third-quarter 2026 financial results, with product revenue rising 16% year over year to $2.0 million.
- The Motley Fool · Aug 20, 11:13 AM EDTNeuroOne (NMTC) Q3 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- The Motley Fool · Jun 1, 11:58 AM EDTNeuroOne (NMTC) Q2 2026 Earnings Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- Fintel · Apr 27, 9:37 PM EDTNeuroOne Medical Technologies (NMTC) Price Target Increased by 500.01% to 12.44The average one-year price target for NeuroOne Medical Technologies (NasdaqCM:NMTC) has been revised to $12.44 / share. This is an increase of 500.01% from the prior estimate of $2.07 dated April 12, 2026. The price target is an average of many targets provide
- BNK Invest · Mar 3, 2:07 PM ESTTuesday 3/3 Insider Buying Report: SOFI, NMTCAs the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy — they expect to make money. So let's look at two noteworthy recent insider buys. On Monday, SoFi Technologies' Chief Executive Officer, Anthony Noto, made a $1.00M
- Fintel · Mar 2, 9:04 AM ESTJones Trading Initiates Coverage of NeuroOne Medical Technologies (NMTC) with Buy RecommendationFintel reports that on March 2, 2026, Jones Trading initiated coverage of NeuroOne Medical Technologies (NasdaqCM:NMTC) with a Buy recommendation. Analyst Price Forecast Suggests 249.94% Upside
- The Motley Fool · Feb 17, 9:38 AM ESTNeuroOne (NMTC) Q1 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- Zacks · Jan 6, 10:00 AM ESTBest Momentum Stocks to Buy for January 6thRIGL, CM and NMTC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 6th, 2026.
- Zacks · Jan 6, 5:33 AM ESTNew Strong Buy Stocks for January 6thILPT, NMTC, RIGL, RIO and BHP have been added to the Zacks Rank #1 (Strong Buy) List on January 6th, 2026.
- RTTNews · Oct 7, 12:41 AM EDTTELO, PCSA, RVPH, NMTC, BRTX Jump In After-Hours Trading On Light News Flow And Select Updates(RTTNews) – Small-cap biotech stocks TELO, PCSA, RVPH, NMTC, and BRTX posted sharp after-hours gains on Monday, with moves driven by a mix of fresh company updates and speculative trading in the absence of new disclosures.
- RTTNews · Oct 1, 12:17 AM EDTBiotech Stocks Rebound After Hours Amid Broader Sector Tailwinds(RTTNews) – Biotech stocks posted strong after-hours gains Tuesday, with several small-cap names rebounding despite limited news flow. Broader sentiment may have been supported by Pfizer's announcement of U.S. drug price cuts and a $70 billion investment in domestic manufacturing
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for NeuroOne Medical Technologies Corporation from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.